Out of more than 113,000 people in Singapore who received the COVID-19 vaccine to date, three have developed severe allergic reactions.

The Ministry of Health (MOH) confirmed on Thursday (28 Jan) that the three individuals, who are in their 20s and 30s, had exhibited symptoms such as rash, lip swelling, throat tightness, giddiness, and breathlessness as a result of reactions to the vaccine, also known as anaphylaxis.

While all three have had a history of allergies to food or allergic rhinitis, none have had a history to anaphylaxis. If they have had a known history of anaphylaxis, they would not have qualified to receive the vaccine.

Following the allergic reactions, MOH confirmed that the three have received treatment and have now been discharged from hospital.

According to figures, the incidence rate of anaphylaxis in Singapore is approximately about 2.7 per 100,000 doses administered, in line with rates reported in other countries.

MOH reiterated that the benefits of getting vaccinated far outweigh the risk of any potential adverse effects and that the Ministry will “closely monitor the safety of the vaccine and ensure the vaccines used in Singapore are safe for our population groups” as the vaccination programme is rolled out.

As of Wednesday (27 Jan), MOH revealed that it was aware of 432 “adverse event reports” from healthcare workers. The symptoms such as injection site pain and swelling, fever, headache, fatigue, body aches, giddiness, nausea, and allergic reactions (such as itch, rash, swelling of eyes or lip) were not unexpected and passed on their own after a few days.

In addition, the Ministry has unveiled a new scheme, the Vaccine Injury Financial Assistance Programme (the Programme), to provide financial aid to those who may, unfortunately, develop serious side effects to the COVID-19 vaccine. Although these potential side effects will be rare, the scheme will act as a safeguard, and will cover citizens, permanent residents, and long-term pass holders.

The Programme is anticipated to provide the following tiers of financial support:

  • A one-time payout of up to S$10,000 will be provided to an eligible individual who is hospitalised requiring care in the High Dependency or Intensive Care Unit but subsequently recovers from medically significant serious side effects.
  • A one-time payout of S$225,000 will be provided to an individual who dies or suffers permanent severe disability as a result of COVID-19 vaccination.

To qualify for the Programme, the individual must have received the vaccine in Singapore and must have experienced a potentially life-threatening or fatal side effect that required inpatient hospitalisation or had otherwise caused persistent incapacity or disability.

An independent panel has been assembled to assess and adjudicate the applications for the Programme.

Subscribe
Notify of
13 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

Opposition is becoming mainstream with more professionally and academically ‘qualified’ candidates like in PAP: WP’s Yee Jenn Jong

While speaking at a forum organised by Mothership on Saturday (6 February),…

AWARE calls on Viswa Sadasivan to make a full and unreserved apology

AWARE Singapore has issued a follow-up statement in relation to to the…

其中一人曾出席君悦酒店会议 本地增两起确诊新冠病例

根据卫生部文告,截至今日(6日)下午2时,本地再添两起2019新型冠状病毒(2019-nCoV)确诊病例, 第29起病例是一名41岁国民,近期也未曾到过中国。他在上月28日出现发烧症状,隔日到诊所就诊;在30日再向另一家综合诊所求医,并于本月3日送往伊丽莎白诺维娜医院。他在本月5日晚11时确诊。 当局目前已追踪曾与上述病例接触的人士,并调查他是否与此前来自大陆确诊病例有关联。 第30起确诊病例,则是27岁国民,他在今日2时确诊。他同样未曾到过中国,但在本月20至22日,曾出席在君悦酒店(Grand Hyatt)举行的国际商务会议,该会议有来自包括中国湖北的代表出席。 上述会议至少获得94名海外人士出席,包括一名马来西亚男子和两名韩国人回国后确诊。 一病患入加护病房 最新两起确诊病例已获隔离,情况稳定。除了此前已出院的第七起病例,剩余27起病例大多稳定和好转,惟其中两位病患情况恶化,其中一人入加护病房(ICU),另一病例则需额外氧气支持。 截至6日中午12时,共有310宗疑似病例经测试对新冠病毒呈阴性反应,仍有147宗疑似病例待检测结果。此外,该部确认多达435人曾于病例接触人士,其中353人仍在新加坡,并与其中348人取得联系,并予以隔离。 此前的28起病例都涉及来自中国武汉的旅客,或是曾与中国旅客接触的人士,这些病例都已获隔离。有鉴于中国海外的一些案例,该部称必须对于社群内本地人感染的可能性做好准备。 该部称早前已加强预防措施,以减少新冠在社区中传播的风险。 “一旦我们从正在进行的调查中获得了一些发现,我们随时准备进一步加强措施。”

Danger in our education system

Is our education system slanted towards favouring the elite?